2023
DOI: 10.1038/s41375-023-01865-5
|View full text |Cite
|
Sign up to set email alerts
|

Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijacking

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2

Relationship

4
2

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 15 publications
0
5
0
Order By: Relevance
“…A few examples of enhancer-hijacking have been reported in the literature for myeloid leukemia in inv(3;3)/t(3;3) AML 11 and atypical 3q26/MECOM rearranged AML 12 . Enhancer-hijacking in the AML cell line, GDM-1, was recently reported as a result of a t(6;7)(q23;q36) and leads to activation of MNX1 through the interaction of the MNX1 promoter with an enhancer in the MYB locus 10 . Enhancer-hijacking events resulting in the activation of proto-oncogenes have been described also in other human malignancies including translocations resulting in the activation of oncogenes MYC , BCL2 or CCND1 in B-cell lymphoma 2325 or rearrangements in medulloblastoma 26 .…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…A few examples of enhancer-hijacking have been reported in the literature for myeloid leukemia in inv(3;3)/t(3;3) AML 11 and atypical 3q26/MECOM rearranged AML 12 . Enhancer-hijacking in the AML cell line, GDM-1, was recently reported as a result of a t(6;7)(q23;q36) and leads to activation of MNX1 through the interaction of the MNX1 promoter with an enhancer in the MYB locus 10 . Enhancer-hijacking events resulting in the activation of proto-oncogenes have been described also in other human malignancies including translocations resulting in the activation of oncogenes MYC , BCL2 or CCND1 in B-cell lymphoma 2325 or rearrangements in medulloblastoma 26 .…”
Section: Discussionmentioning
confidence: 96%
“…The first clue for the existence of possible aberrant promoter-enhancer interactions leading to MNX1 activation came from our investigations of the GDM-1 AML cell line which harbors a t(6;7)(q23;q36) translocation. In GDM-1, the MNX1 promoter interacts with an enhancer element from the MYB locus on chr6q23 10 .…”
Section: Introductionmentioning
confidence: 99%
“…Cell lines continue to be a vital resource for functional studies. Several well-established cancer cell lines are highly rearranged, with underreported genomic complexity ( Nattestad et al, 2018 ; Aganezov et al, 2020 ; Weichenhan et al, 2023 ). Despite its frequent use for functional and mechanistic studies in leukemia research ( Oshima et al, 2020 ; Diedrich et al, 2021 ; Cousins et al, 2022 ; Leo et al, 2022 ; Wray et al, 2022 ), a comprehensive analysis of the complex REH genome has never been undertaken.…”
Section: Discussionmentioning
confidence: 99%
“…The alignments and “basemod_freq” tracks can display allele-specific DNA methylation. The leukemic cell line GDM-1 harbours a translocation between chromosomes six and seven, which activates MNX1 by enhancer hijacking 12 . By visualizing allele-specific methylation in this region using figeno, we observed allele-specific methylation, where the wild type allele is methylated at the MNX1 promoter while the rearranged allele is hypomethylated (Fig.1D).…”
Section: Figeno: a Flexible Versatile And User-friendly Solution For ...mentioning
confidence: 99%